Kanika Bahl
About Kanika Bahl
Kanika Bahl is the CEO and President of Evidence Action, known for her leadership in expanding the organization's reach and impact.
Kanika Bahl - CEO & President of Evidence Action
Kanika Bahl serves as the CEO and President of Evidence Action. Since assuming this role, she has been pivotal in enhancing the organization's reach and influence. She brings a focused approach to operational scalability and cost-effectiveness, leveraging data-driven strategies to maximize impact. Under her leadership, Evidence Action has expanded its programs across nine countries.
Kanika Bahl on the Board of Evidence Action
Kanika Bahl has been a Board Member of Evidence Action since 2015. During her tenure, she has played a critical role in guiding the organization through significant growth and development. She has championed initiatives that prioritize transparency and high impact, contributing to Evidence Action's recognition by award bodies like Charity Navigator.
Achievements in Delivering Deworming Treatments and Safe Water
Throughout her leadership at Evidence Action, Kanika Bahl has overseen the delivery of 1.8 billion deworming treatments and facilitated access to safe water for over 10 million people. These accomplishments reflect her commitment to scalable and cost-effective solutions to global health challenges, ensuring high-impact interventions reach those in need.
Driving Data-Driven Approaches in Global Health
Kanika Bahl has been instrumental in driving Evidence Action's data-driven approach, focusing on scalability and cost-effectiveness. Her strategic direction has enabled the organization to implement evidence-based programs effectively, ensuring that resource allocation is optimized for maximum impact. This focus has helped Evidence Action maintain its reputation as a leading non-profit in global health.